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ABSTRACT
We have used the fC31 integrase to introduce large
DNA sequences into a vertebrate genome and meas-
ure the efficiency of integration of intact DNA as a
function of insert size. Inserts of 110 kb and 140 kb
in length may be integrated with about 25% and 10%
efficiencyrespectively.Inordertoovercometheprob-
lems of constructing transgenes longer than  150 kb
we have established a method that we call; ‘Iterative
Site Specific Integration’ (ISSI). ISSI combines the
activities of fC31 integrase and Cre recombinase
to enable the iterative and serial integration of trans-
genicDNAsequences.Inprincipletheproceduremay
be repeated an arbitrary number of times and thereby
allow the integration of tracts of DNA many hundreds
of kilobase pairs long. In practice it may be limited by
thetimeneededtochecktheaccuracyofintegrationat
each step of the procedure. We describe two ISSI
experiments, in one of which we have constructed a
complexarrayofvertebratecentromericsequencesof
150 kb in size. The principle that underlies ISSI is
applicable to transgenesis in all organisms. ISSI
may thus facilitate the reconstitution of biosynthetic
pathways encoded by many different genes in trans-
genic plants, the assembly of large vertebrate loci as
transgenesandthesynthesisofcompletegenomesin
bacteria.
INTRODUCTION
Site-speciﬁc recombinases are used to manipulate chromo-
somal DNA sequence organization in vivo, in vitro (1) and in
a range of different experimental systems. The enzymes Cre
and Flp (2) are the most widely employed, both are members
of the tyrosine recombinase family and catalyse reversible
reactions between identical sites of  35 bp in the absence
of any accessory proteins. The reversibility of the reactions
catalysed by these enzymes has limited their applicability.
They are generally used to promote deletion reactions
since integration reactions are kinetically unfavourable.
However Cre and Flp have also been used to engineer
integrations and translocations in cells in culture where it
has been possible to provide the enzyme transiently and
trap the potentially unstable product, often but not always,
by selection (3,4).
A technology that would allow the construction of large
segments of transgenic DNA would be of widespread utility.
Thus it would be valuable to be able to assemble large tracts of
transgenic DNA at deﬁned chromosomal loci in order to con-
struct animal modelsof humangenetic disease and to study the
factors controlling expression of large genes. This goal has
become more attractive with the ability to precisely and efﬁ-
ciently manipulate DNA cloned in Escherichia coli by homo-
logous recombination (5,6) and with the availability of a
complete genome sequence and well-characterized libraries
of bacterial artiﬁcial chromosome (BAC) clones. Similarly
it would be useful to be able to build plants with multiple
transgenes at a single locus. Finally it would be interesting
to be able to construct synthetic bacterial genomes in order to
identify the minimal set of genes consistent with independent
life (7). Strategies describing how Cre or Flp might be used to
promote irreversible integrations have been presented (8–10)
However all of these approaches suffer from the limitation
that they only allow one cycle of site-speciﬁc recombination
and thus cannot be used iteratively. It is difﬁcult therefore to
see how they could be used to construct large tracts of trans-
genic DNA.
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doi:10.1093/nar/gni192Here we investigate the use of an integrase from the Strep-
tomyces’ phage fC31 (11); this integrase belongs to the serine
recombinases family of proteins and is thus releated to the
resolvase/invertases. fC31 integrase is one of an expanding
group of so-called ‘large serine recombinases’ because of their
much higher molecular weight compared with the resolvase/
invertases. The serine recombinases differ evolutionarily and
mechanistically from the tyrosine recombinases such as Cre
and Flp. Several phage integrases of the large serine recom-
binases have been shown to promote unidirectional or irre-
versible recombination between non-identical sites of  50 bp
in vitro in the absence of additional proteins (11,12). They
would thus be potentially ideal for engineering precisely those
types of re-arrangement that cannot be promoted by Cre and
Flp. Several such phage integrases have been shown to be
active in vertebrate cells (13). However these reports did
not include unambiguous measurements of the efﬁciency of
the reactions promoted by these proteins but emphasized the
suggestion that exchange reactions could occur ectopically
between one or other of the speciﬁc sites and several genomic
sites (13). Such ectopic recombination would, of course, com-
promise the utility of these enzymes for genome engineering
but, it was argued, enhance their utility as reagents for gene
therapy.
Here we measure the efﬁciency of the class V serine recom-
binase: fC31 integrase (11), in chicken DT40 cells. We show
that this enzyme can be used to promote the efﬁcient integ-
ration of plasmids and fragments as large as 100 kb into ver-
tebrate chromosomes. Sequences larger than 100 kb are more
frequently deleted than integrated intact. In order to overcome
this limitation we have established a method that enables the
iterative integration of transgenic DNA sequences by combin-
ing the site-speciﬁc recombinase activities of the fC31 integ-
rase and Cre recombinase. This method which we call
‘iterative site-speciﬁc integration’ (ISSI) potentially enables
the reconstitution of transgenes of unlimited length and
deﬁned sequence organization. We describe proof of principle
experiments in which we have constructed an array of plasmid
DNAsequences anda complex arrayofvertebrate centromeric
sequences of 150 kb in size. Although our experiments have
been carried out in vertebrate cells the principle that underlies
ISSI is simple and applicable to transgenesis in all organisms:
plants and bacteria as well as animals. ISSI should thus enable
the reconstruction of complete genomes in bacteria and of
biosynthetic pathways encoded by many different genes in
transgenic organisms. A merit of assembling transgene arrays
at a single locus in whole organisms using a technique such as
ISSI is that doing so would avoid the difﬁculties that would
arise as a result of the segregation of independent transgenic
loci during meiosis.
In our proof of principle experiments we have used site-
speciﬁc recombination to introduce long, deﬁned tracts of
tandemly repeated DNA into hyper-recombinogenic cells
derived from the DT40 cell line. Thus we have demonstrated
that long tracts of repeated DNA sequences can be introduced
into a cell line where such sequences might be expected to be
particularlyunstable. These experimentsthereforesuggestthat
ISSI may be useful in a wide variety of cell types and for a
variety of different sequences. However some cell types may
be less readily transfected with large DNA than DT40 cells
or may process such sequences differently from DT40 cells.
Serine recombinases have been shown to work in many cells
types but there may be some where they do not and in these
implementation of ISSI would be impractical.
MATERIALS AND METHODS
Plasmid construction
Plasmids were constructed by standard techniques including
recombineering using the DY380 strain of Court and cowork-
ers (14). The sequences of the plasmids and of the integrases
used in this work can be obtained from http://www.
nottingham.ac.uk/genetics/brown/genomeengineering.php.
The Y chromosome alphoid (DYZ3) DNA BAC used in these
experiments was 442H19 from the CITB Human BAC DNA
(B and C libraries) Release 4. The original BAC had an insert
of150kb ofhumanYalphoidDNAbutwasunstableinculture
and derivatives of varying sizes could be isolated from col-
onies left on plates for several weeks. The BAC 442H19 was a
kind gift of Jonathan Flint and colleagues of the Wellcome
Trust Centre for Human Genetics,Oxford. The X chromosome
alphoid (DXZ1) DNA was derived from a PAC subclone of
BAC RPCI-11 242E23 kindly provided by Hunt Willard and
colleagues. The nuclear localization signal used to tag the
fC31 was derived from the large T antigen of SV40 virus
and included the residues MPKKKRKV. The attP and attB
used sites were as follows: gtagtgccccaactggggtaaccttt-
gagttctctcagttgggggcgtag and ccgcggtgcgggtgccagggcgtg-
cccttgggctccccgggcgcgtactcc for the standard integration.
The sequence of the modiﬁed attB site used in the ISSI con-
structs was accgcggtgcgggtgccagggtgtgcccttgggctccccaggg-
cacccctccac. In each case these att sites were engineered
into plasmids using synthetic DNA provided by Invitrogen.
The plasmids were checked by restriction site mapping and in
all cases by sequencing across the att sites. The gene encoding
resistance to apramycin was as described by Kuhstoss et al.
(15).Theblasticidinresistance(BSR)(16) genewas akindgift
from Hiroshi Arakawa of the GSF, Munich. The hygromycin
resistance gene used was present in the counter selectable
hygromycin–thymidine kinase fusion (HyTk) (17). The
CCAG promoter (18) was a kind gift of Ian Chambers (Edin-
burgh University). Primers used in the PCR are given in Sup-
plementary Table 1. All plasmids and vectors are available
from WRAB subject to a materials transfer agreement. Plas-
mid DNA was puriﬁed by alkali lysis and precipitation with
polyethylene glycol. BACs and PACs were puriﬁed initially
by alkali lysis and density gradient centrifugation in mixtures
of caesium chloride and ethidium bromide (experiments
shown in Figure 4) and subsequently by alkali lysis and
PEG precipitation (experiments shown in Figure 8).
Cell culture
DT40 cells and DT40 somatic cell hybrids were as described
(19) and were maintained and electroporated as also described
previously (19) except that the medium used was RPMI 1640
including 446 mg/l L-alanyl-L-glutamine with 10% foetal
bovine serum, 1% chicken serum, 10
 5 M 2-mercapto-
ethanol, 10 U/ml penicillin and 10 mg/ml streptomycin.
This medium gave cleaner selection after addition of antibi-
otics than our earlier DMEM based medium. Targeting of the
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the mini-chromosomes was detected by digestion with SacI,
hybridization with an alphoid DNA probe and the replacement
of a 20 kb SacI fragment by one of 17 kb in size. The
site-speciﬁc integration experiments were carried out as fol-
lows: cells were electroporated in the usual conditions with the
indicated amount of DNA and immediately after transfection
were plated out in 96-well dishes. Selection was applied 18 h
later.DT40 colonies were countedafter12–14daysandcounts
were corrected using the Poisson distribution for the small
underestimate arising from the random distribution of trans-
fected cells into a limited number of wells. The efﬁciencies
given in Tables 1 and 2 are the total number of resistant
colonies recovered divided by the total number of cells elec-
troporated. We refer to this ﬁgure as the absolute efﬁciency of
integration in the table headings and text.
PCR and filter hybridization analysis
Conventional agarose and pulsed-ﬁeld gels were as described
previously (19). Filter hybridization was as described (19).
The sequences of the primers used in the PCR to check the
breakpoints in the fC31 integration reactions and in the ISSI
reaction sequence (Figure 7) are given in the Supplementary
Data (Table 1). The markers used in Figure 4C were the mid-
range I PFG set from New England Biolabs. The sizes of the
informative marker molecules are 15, 33, 48.5, 63.5, 82, 97,
112, 130.5, 145.5 and 160.5 kb. The conditions for the PCR in
Figures 3 and 4 and Supplementary Figure 2 (attL) are as
follows 35 cycles: 92 C for 20 s, 62 C for 20 s and 72 C
for 30 s. The buffer used was a 16 mM (NH4)2SO4,6 7m M
Tris–HCl, pH 8.8, 0.1% Tween-20, 1 mM MgCl2 and the Taq
polymerase was from Bioline. The primer sequences used are
giveninSupplementaryTable1.TheattBprimerswere usedat
400 nM and the attP primers at 200 nM ﬁnal concentrations.
Markers used in the PCR in Figure 4 were the 100 bp ladder
from NEB.
RESULTS
fC31 integrase in DT40 cells
We initiated our experiments by studying the ability of the
fC31 integrase (11) to promote site-speciﬁc integration of a
closed circular plasmid into a genomic locus. In order to do
this we ﬁrst of all used sequence targeting to introduce an attB
site into a deﬁned position on a human mini-chromosome
contained in a DT40 hybrid cell line. The attB site was placed
between the CCAG promoter (18) and the coding region of the
hygromycin–thymidine kinase (17) fusion gene. The mini-
chromosome used in these experiments was the 49B(A)A9
mini-chromosome (Figure 1A) that was derived from the
human Y chromosome and is described in detail elsewhere
(19). This mini-chromosome is largely composed of DYZ1,2
repeated sequences but contains two arrays of alphoid DNA
at one end of the chromosome. These are 15 and 90 kb in size.
The attB targeting construct disrupted the G418 resistance
gene at the left hand end of the chromosome (Figure 1B)
(19). Next we wanted to express the fC31 integrase in the
cells containing the modiﬁed mini-chromosome. The fC31
integrase is 68 kDa in molecular weight and is of bacterial
origin. It therefore seemed likely that it would need a nuclear
localization signal to function in our experiments. Therefore
we introduced sequences encoding either the native
fC31 integrase or the integrase tagged at either the N- or
C-termini with the SV40 virus large T antigen nuclear
localization signal into an expression vector, CCAG IRES
zeo (Figure 2A) that conferred zeocin resistance upon
Table 2. Assaying the efficiency of integration of BAC DNA promoted by the fC31 integrase alone and during ISSI into a mini-chromosome DT40 cells
Transfection
number
Cell line BAC Amount
mg
Number of cells
transfected
% plated
out
Resistant
clones
Number of clones
analysed
No
intact
19 50NLS2 33 kb a attPneoBAC 48 2.0 · 10
8 100 41 20 13
51 50NLS2 70 kb a attPneoBAC 190 2.0 · 10
8 100 1078 39 20
72 50NLS2 110 kb a attPneoBAC 520 2.75 · 10
8 100 158 39 7
53 50NLS2 140 kb a attPneoBAC 88 2.0 · 10
8 100 288 39 4
419 ISSI 293 80 kbX a BBLoxPBSR BAC 500 5.7 · 10
8 100 >2000 20 4
Table 1. Efficiency of site-specific integration of plasmid DNA promoted by fC31 integrase alone and in conjunction with Cre recombinase (ISSI)
Transfection Cell line Transfected
plasmid
Amount
(mg)
Number of cells
transfected
% plated
out
Number of stably
transfected colonies
Absolute
efficiency
4.8.02 A9-CCAGattBHyk fc31 integrase attPneo 50 5.7 · 10
7 100 0 <2 · 10
 8
2.5.01 A9-CCAGattBHyk fc31-50NLS1 attPneo 100 3.2 · 10
7 100 2912 9.1 · 10
 5
4.5.01 A9-CCAGattBHyk fc31-50NLS2 attPneo 100 3.2 · 10
7 100 3920 12.2 · 10
 5
39 A9-CCAGattBHyk fc31-50NLS2 attPneo 25 2.34 · 10
7 25 90 1.53 · 10
 5
40 A9-CCAGattBHyk fc31-50NLS2 attPneo 250 2.34 · 10
7 25 379 6.47 · 10
 5
41 A9-CCAGattBHyk fc31-50NLS2 attPneo 25 2.45 · 10
8 25 389 0.66 · 10
 5
42 A9-CCAGattBHyk fc31-50NLS2 attPneo 25 1.24 · 107 25 31 0.96 · 10
 5
43 A9-CCAGattBHyk fc31-50NLS2 attPneo 250 1.24 · 10
7 25 398 12.8 · 10
 5
44 A9-CCAGattBHyk fc31-50NLS2 attPneo 25 1.24 · 10
8 25 315 1.01 · 10
 5
89 A9-CCAGattBHyk fc31-30NLS2 attPneo 100 2 · 10
7 25 433 8.66 · 10
 5
98 A9-CCAGattBHyk fc31-30NLS2 attPneo 25 3.8 · 10
7 25 152 1.6 · 10
 5
304 288-ISSI BBloxPBSR 20 5 · 10
7 25 226 1.8 · 10
 5
PAGE 3 OF 14 Nucleic Acids Research, 2005, Vol. 33, No. 22 e189Figure 2. Plasmidsusedto studythe activityof thefC31integrasein DT40 cells.(A) CCAG(50NLS)fC31integraseIRESZeo isthe canonicalintegraseexpression
plasmid. It contains the fC31integrase gene either with or without an N-terminal nuclear localization signal cloned into the internal ribosome entry site containing
expression vector CCAG IRES Zeo that confers resistance to the antibiotic zeocin. (B) fCattPneo is the promoterless trapping vector in which a coding region
potentially capable of conferring resistance to the antibiotic G418 is abutted by a fC31attP site. (C) Apra fC31attPneo/pBAC3e is the BAC vector designed for
trapping with the fC31 integrase. As in pBACe3.6 the cloning sites are interrupted by a pUC plasmid.
Figure1.Engineeringamini-chromosomewithanattBsiteforthefC31integrase.(A)Themini-chromosome49B(A)A9is 1.8Mblongandconsistsmainlyoftwo
arrays of repeated sequences. There is a 1.6 Mb array consisting of interspersed DYZ1 and DYZ2 sequences at the end of the mini-chromosome nearest a sub-
telomeric puromycin resistance gene. The other end of the mini-chromosome includes sequences necessary for mini-chromosome maintenance in Saccharomyces
cerevisiae (ACU), plasmid vector sequences (pBS), a gene conferring resistance to the antibiotic G418 (neo), a 15 kb array of alphoid DNA and a 90 kb array of
alphoidDNA.The two alphoidDNA arrays are separated by between30 and 50 kb ofconventionaleuchromaticDNA thathas been clonedand mappedin bacterial
vectors.Detailsoftheorganizationofthemini-chromosomeandofthecloningandmappinghavebeendescribedelsewhere(19).(B)TheattBsitewastargetedinto
the mini-chromosome with a construct cloned in pBS that included the ACU sequences and homology to the G418 resistance gene. The targeting construct also
containedahygromycinresistancethymidinekinasefusiongenedrivenbyaCCAGpromoterwiththepromoterandcodingsequencebeinginterruptedbyanattBsite
forthefC31integrase.ThearrowabovetheneointheuppermostdiagramindicatesthepositionoftheSV40earlyregionpromoterdrivingtheG418resistancegene
in this chromosome.
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as a bi-cistronic mRNA. We then introduced the linearized
expression vector into DT40 cells containing the attB-modi-
ﬁed mini-chromosome, selected for stably transfected clones
and analysed expression of the integrase gene by western
blotting (data not shown). The results indicated that the integ-
rase comprise 0.01% of the total protein in the respective cell
extracts. We also used immunocytochemistry to conﬁrm that
the protein did not enter the nucleus unless modiﬁed appro-
priately (data not shown).
In order to assay the activity of the integrase in the DT40
cells we assembled a plasmid, fC31 attPneo (Figure 2B), that
contains an attP site for the fC31 integrase 50 to the coding
region of a promoterless G418 resistance gene. The plasmid
fC31 attPneo was then transfected by electroporation into
DT40 cells containing the attB-modiﬁed mini-chromosome
and expressing either the native or nuclear localization
signal modiﬁed fC31 integrase. Transfectants were recovered
in 96-well dishes and G418 selection applied. No G418 res-
istant clones were recovered from the clone (Table 1) express-
ing the native integrase indicating that the background of
integration of the attPneo into the host genome is undetect-
able. The two clones expressing integrase tagged with the
nuclear localization signal each gave G418 resistant clones
at a frequency of  10
 4 per electroporated cell (Table 1).
In these experiments the proteins tagged at the N- and C-
termini with nuclear localization signals were equally efﬁcient
in promoting integration reactions (transfections 89 and 98).
These results therefore do not conﬁrm those of others (20) who
observed that the protein tagged at the C-terminus functions
about three times more efﬁciently than that tagged at the N-
terminus. These differences may reﬂect the nature of the cell
lines used in our respective experiments. We analysed the
products of the transfections of 2.5.01 and 4.5.01 by PCR
(Figure 3). The attL and attR sites were detected in 81 out
of 96 G418 resistant clones. In the other 15 clones one or other
orbothofthe two anticipatedproductswereabsent(e.g. clones
43, 49, 52, 82, 85 and 95 as numbered from the top left), the
clone contained only an attB site (clones 65 and 77) and had
presumably escaped selection or the PCR products were
ambiguously sized (clones 30, 46, 52, 58, 60, 62 and 88).
The clones giving rise to these incorrect products were not
analysed further but their existence indicates the need to con-
ﬁrm by molecular techniques that the products of any selection
are as intended. We sequenced the attR and attL sites of two
clones (1 and 7) as representative of the majority and found
that both were precisely as predicted for accurate site-speciﬁc
recombination. Overall the results of this analysis indicate that
the integrase promotes accurate site-speciﬁc recombination
in chicken DT40 cells. The ﬁdelity of the plasmid integration
reaction into the mini-chromosome was conﬁrmed by gel elec-
trophoresis, ﬁlter transfer and hybridization for two such
clones. The data on one of these clones are illustrated in
Supplementary Figure 1.
Figure 3. Assaying the accuracy of integration promoted by the fC31 integrase in DT40 cells. (A) schematic representation of a fC31 integrase promoted site-
specificintegrationofthepromoterlessfC31attPneotrappingplasmidintotheCCAGattBHyTkgenewithinthemini-chromosomeA9CCAGattBHyTk.(B)PCR
assayfortheaccuracyoftheintegrationpromotedbythefC31integrasewasestablishedusingfourprimerswhichflankedasymmetricallyboththeattBandattPsites
andtheproductattLandattRsites.Thediagramindicatestherespectivepositionsofthedifferentprimercombinations.(C)TheresultsofthePCRassaywhenapplied
to 96 clones isolated as resistant to G418 following transfection of DT40 cells containing the mini-chromosome A9 CCAG attB HyTk and expressing the fC31
integrasewithfC31attPneo.ThecontrolsusedinthisexperimentwereextractsofDT40cellsdopedwithplasmidsCCAGattBHyTkandfC31attPneotosinglecopy
levels. Details of the PCR are given in Materials and Methods and in Supplementary Data.
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reaction varied as a function of cell number and the amount of
DNA in the transfection. We therefore took one cell line (A9-
CCAGattBHyk fC31–50NLS2) expressing the fC31 integrase
tagged at the N-terminus and carried out two further series
of transfections (numbered 39–41 and 42–44) in which we
varied each of these parameters with one of the cell lines
termed NLS2. The results of these experiments (Table 1)
demonstrated that the number of recovered clones increased
in proportion both to the amount of DNA and the number of
electroporated cells and therefore extend the observations
of others who have used the fC31 integrase in a different
context (21).
The results in Table 1 also indicate the reproducibility of the
reaction; reactions carried out within days of one another are
reproducible to within a factor of two but the efﬁciency varies
more over longer intervals. Our earlier reactions (2.5.01 and
4.5.01) were  4-fold more efﬁcient than those carried out
later. We are not sure why this is so. There may be variations
in the quality of the fC31 attPneo DNA used in the transfec-
tion, the cell culture medium or in the epigenetic status of the
target DNA. Despite this relatively small variation the results
demonstrate that the fC31 integrase along with its cognate
attachment sites provides a robust and reliable tool for integ-
rating DNA into vertebrate and other genomes.
Site-specific integration of large DNA fragments
cloned in a BAC vector using fC31 integrase
We wanted to use the fC31 integrase for integration of large
fragments of DNA into deﬁned loci so we next built a BAC
vector, Apra fC31attPneo/pBAC3e (Figure 2C) containing
the attPneo trapping cassette (Figure 2B). We conﬁrmed by
PCR and by gel electrophoresis and ﬁlter hybridization that
this vector integrated in site speciﬁcally (Supplementary
Figure 1). In order to investigate the ability of the fC31 integ-
rase to integrate large fragments of DNA we needed a suitable
test sequence. Alphoid DNA is a tandemly repeated sequence
found at the centromere of human chromosomes and has been
showntobemediatecentromerefunction.Wechose thisasour
test sequence for two reasons. First, it is of low sequence
complexity and so it has a sequence organization that is
easy to analyse; this is a particularly important when one
wishes to establish whether a sequence has been integrated
intact. Second, tandemly repeated sequences are particularly
prone to re-arrangement and thus if we were able to integrate
this sequence intact then we could argue conﬁdently that one
should be able to use the system to integrate a sequence more
typical of vertebrate genomic DNA. We cloned four differ-
ently sized segments of Y chromosome alphoid DNA
(Figure 4A) of 33, 70, 110 and 140 kb into a BAC vector
Apra fC31attPneo/pBAC3e and transfected them into the
DT40 cell line A9-CCAGattBHyTK fC31–50NLS2. The efﬁ-
ciency varied between experiments as would be expected
given variations in the quality of DNA cloned in low copy
number vectors (Table 2) and were lower than with the attP-
neo plasmid. We analysed the G418
r clones recovered after
transfection for the presence of the cloned insert by pulsed-
ﬁeld gel electrophoresis (PFGE), blotting and PCR for the
recombinant attL site (Figure 4C and D and Supplementary
Figure 2). In interpreting the data in Figure 4 it is important to
know that the 49B(A)A9 mini-chromosome (19), derived as
it is, from the human Y chromosome contains alphoid DNA
similar in sequence to that cloned in the BAC vector, Apra
fC31attPneo/pBAC3e and which consequently hybridizes to
the probe used to detect the sequence we are integrating into
the chromosome. This sequence that we are introducing into
the chromosome by site-speciﬁc recombination therefore
appears in addition to pre-existing chromosomal fragments
of 15 and 90 kb that are present on the native 49B(A)A9
mini-chromosome and are detected on the blots shown in
Figure 4B. These blots of the transfected clones demonstrated
that we could recover clones in which the DNA had integrated
intact (lanes denoted as N in Figure 4C). These blots also show
a change in size of the 15 kb alphoid fragment present on the
native chromosome in those clones in which the BAC has
integrated. This change in fragment size arises because the
15kbalphoid fragment ispresentonthe sameSacIfragmentas
the integration site (for the positions of these two sequences
see Figure 1). Site-speciﬁc integration introduces both the
alphoid DNA insert and the BAC vector and thereby intro-
duces a new SacI site immediately adjacent to the 15 kb
alphoid DNA. This leads to the change in size of the smaller
fragment. Not surprisingly the efﬁciency with which we
recovered clones with intact BAC insert declined with the
size of the insert so that with the 140 kb BAC we were
only able to recover intact BAC in 10% of the G418
r clones
(Figure 4C and Table 2). The G418
r clones which did not
contain the intact insert were found to be of two types (indic-
ated above the lanes in Figure 4C). Type 1 re-arrangements
were often mixtures of inserts of two different sizes. These
clones contained both recombinant attL and attR sites
(Figure 4D). This type of clone was predominant in the
case of the 70 kb BAC. We suggest that these re-
arrangements arose as a result of the incoming BAC being
nicked or otherwise damaged on one strand and that this dam-
age was repaired by gene conversion at DNA replication from
the undamaged sister chromatid. We suggest that the deletions
in the products of the repair arise as a result of the gene
conversion events occurring between tandemly repeated
arrays that were aligned out of register. In some cases the
BAC was detectably repaired from the alphoid DNA already
present on the A9 mini-chromosome as judged by a deletion
in this DNA; these events are referred to as 1* and one of these
is shown in the panel illustrating the data obtained with the
140 kb BAC. The type II events contained no detectable insert
but are G418
r. PCR and ﬁlter hybridization analysis showed
that these clones were deleted for sequences ﬂanking the
expected attL and attR sites (Figure 4D). These clones may
have arisen as a result of a double-strand break in the CCAG-
fCattB-HyTk gene being resected and repaired by ligation
to the neo coding sequence native to the 49B(A)A9 mini-
chromosome. Alternatively they may have arisen by site-
speciﬁc integration of a BAC with a double-strand break
being resected prior to a similar non-homologous repair pro-
cess. Since we see few such clones in the control transfections
where we do not transfect with BAC DNA we consider the
second explanation more likely but have no way of
proving this interpretation. The goal of our project and of
others is to be able to integrate DNA intact rather than re-
arranged and so we did not characterize these re-arrangements
in any more detail.
e189 Nucleic Acids Research, 2005, Vol. 33, No. 22 PAGE 6 OF 14Iterative site-specific integration of transgenic
DNA fragments
The results described in Table 2 and Figure 4 demonstrate that
while it is possible to integrate large DNA fragments clones
containing the intact integrated molecule are a small percent-
age of the stably transfected clones if the incoming molecule is
much bigger than 100 kb. It would be useful however to be
able to assemble larger stretches of transgenic DNA than are
implied by this ﬁgure. For example it would be valuable to be
able to build transgenic mice containing human gene families
of medical importance. This goal could be achieved by com-
bining the activities of a unidirectional and reversible recom-
binase as outlined in Figure 5. In this strategy a modiﬁed
selectable marker gene is ﬁrst introduced into a chromosome
and then used as a seed from which the transgenic sequences
are grown. The modiﬁcations of the selectable marker are
envisaged as follows; a site for a reversible recombinase;
e.g. a loxP site for Cre recombinase is placed between the
promoter and coding region of the gene and an att site for a
unidirectional site-speciﬁc recombinase such as fC31 integ-
rase is placed at the 30 end of the gene. In this example the site
is chosen, arbitrarily to be an attP site. Plasmids that direct
expression of the Cre recombinase and a unidirectional site-
speciﬁc recombinase are then introduced into the cells con-
taining the modiﬁed selectable marker gene. This modiﬁed
selectable marker gene can then be used as the site from
which inserts in circular DNA molecules; typically cloned
in plasmid, cosmid or BAC vectors are iteratively introduced
into the chromosome as described in the following.
Figure 4. fC31integrasemediatedintegrationofalphoidDNAinsertsclonedinaBACtrappingvectorintomini-chromosomeA9CCAGattBHyTkinDT40cells.
(A) Pulsed-field gel analysis of Y alphoid DNA sequences of 30, 70, 110 and 140 kb cloned in BAC vector AprafC31attPneo/pBAC3e. (B) Restriction and filter
hybridizationanalysisofthemini-chromosomeA9CCAGattBHyTk.FollowingdigestionwithSacItheDNAwassizefractionatedbyPFGE.Hybridizationanalysis
wascarriedoutusingaprobespecificforalphoidDNA.Thearrowsindicatethe90and15kbalphoidDNAfragmentsendogenoustothisstartingmini-chromosome.
The marker used in this gel was a collection of multimers of the phage l cI857 genome (48.5 kb). (C) Restriction and filter hybridization analysis of the mini-
chromosome A9 CCAG attB HyTk following site-specific integration of the BACs containing inserts of Y chromosome alphoid DNA of the indicated sizes.
Followingdigestion with SacI the DNA was size fractionatedby PFGE. Hybridization analysis was carriedout using a probe specific for alphoid DNA.The arrows
indicate the 90 and 15 kb alphoid DNA fragments endogenous to the starting mini-chromosome. The left most track in each panel was of a SacI digest of DNA
extracted from a site-specific recombinant between a BAC containing a 33 kb insert and the mini-chromosome A9 CCAG attB HyTk. The penultimate track in the
110 kb panel includes degraded DNA but was shown to derive from an undeleted integrant in a separate gel. The marker used in this gel was a collection of
concatamersoftheintactandXhoIdigestedphagelcI857genome(48.5kb).SizesinMaterialsandMethods.(D)PCRanalysisoftherecombinantattLandattRsites
generated by site-specific recombination between the incoming BAC DNA and the resident mini-chromosome A9 CCAG attB HyTk in a selection of clones
containingre-arrangedDNA.TheaberrantlysizedattLsiteinthetype2re-arrangementindicatedwithanasteriskisconsistentwithdeletionofsequencesbetweenthe
two primer binding sites.
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termed vector 1. Vector 1 consists of a circular piece of recom-
binant DNA containing a second selectable marker gene and is
abutted at the 50 end of the coding region by a loxP site. Two
copies of an att site reciprocal to that already integrated into
the genome ﬂank the insert cloning site in vector 1. In this
example the att site would be an attB site. The recombinant
DNA molecule in vector 1 is introduced into the cells con-
taining the chromosome modiﬁed as described above and
expressing both the Cre recombinase and unidirectional
site-speciﬁc recombinase. Selection is applied such that
cells expressing the marker gene in vector 1 survive. These
cells would be expected to be enriched in those in which the
Cre recombinase has catalysed recombination between the
resident chromosomal loxP site and the loxP site cloned in
vector 1.
Step 2: As a result of the action of the Cre recombinase the
insert contained within vector 1 is introduced into the chro-
mosomal site and the two attB sites originally present in vector
1 are separated by the insert such that one is closer to the
previously resident attP site. One of the two loxP products of
the Cre mediated reaction is between the promoter and the
marker gene contained within vector 1 while the second is
between attP and attB sites. The next reaction to consider is
that promoted by the unidirectional site-speciﬁc integrase
which leads to the excision of the second loxP. The excision
reaction may occur between the attP site and either of the two
attB sites present in the incoming vector 1. If,as illustrated, the
attB site nearest to the attP site participates in the unidirec-
tional recombination reaction then the original marker gene
and the loxP site adjacent to marker 1 is excised on a small
circular fragment which would be expected to be lost from the
nucleus at cell divison. The insert and attB site from vector 1
remain but loss of one of the two loxP sites renders the Cre
catalysed integration irreversible. Alternatively if the attB site
nearest to the second marker gene participates in the unidir-
ectional recombination reaction then the ﬁrst marker, a loxP
site and the insert in the ﬁrst vector will be excised. The ﬁrst of
these two alternative unidirectional recombination reactions is
necessary for the next step in the sequence because the integ-
rated product can function as a substrate for another sequence
of site-speciﬁc recombination reactions that can lead to the
integration of a second insert.
Step 3: A desired segment of DNA is cloned in what is here
termed vector 2. Vector 2 consists of a circular piece of recom-
binant DNA containing the original selectable marker gene
and is abutted at the 50 end of the coding region by a loxP site.
Two copies of an att site that can function as a substrate for the
integrase and reciprocal to the site now integrated into the
genome ﬂank the insert cloning site in vector 2. In this
example the att site would be an attP site. The recombinant
DNA molecule in vector 2 is introduced into the cells con-
taining the chromosome modiﬁed as described above as a
products of steps 1 and 2 and expressing the Cre recombinase
and unidirectional site-speciﬁc recombinase. Selection is
applied such that cells expressing the marker gene in vector
2 survive. These cells would be expected to be enriched in
those in which the Cre recombinase has catalysed recombina-
tion between the resident chromosomal loxP site and the loxP
site cloned in vector 2.
Step 4: As a result of the action of the Cre recombinase the
insert contained within vector 2 is introduced into the chro-
mosomal site and the two attP sites originally present in vector
2 are separated by the insert two such that one is closer to the
attB site arising from the preferred reaction occurring in step 2
of the process. As above one of the two loxP products of this
Figure 5. A schematic illustration of how ISSI might occur. Details are discussed in the text.
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gene contained within vector 1while the secondisbetweenthe
attB site and attP site. Once again we now consider the reac-
tion promoted by the unidirectional site-speciﬁc integrase
which as in step 2 leads to the excision of the second loxP
site. The excision reaction may occur betweenthe attB site and
either of the two attP sites originally present in the incoming
vector 2. If, as illustrated, the attP site nearest to the attB site
participates in the unidirectional recombination reaction then
the marker gene 2 and the adjacent loxP site are excised to
generate an unstable product. The insert and attP site from
vector 2 remain but the loss from the cell of the small circular
molecule generated by the integrase would render the Cre
catalysed reaction irreversible. Were the attP site nearest to
the second marker gene to participate in the unidirectional
recombination reaction then marker 2, a loxP site and the
second insert would be excised. The ﬁrst of these two altern-
ative unidirectional recombination reactions is, of course, pre-
ferred because as before the integrated product can function as
a substrate for another sequence of site-speciﬁc recombination
reactions that can lead to the integration of a third and sub-
sequent inserts because it creates a target identical to that with
which the process was started. The reaction series of steps 1–4
may therefore be repeated an arbitrary number of times. We
refer to this strategy as ISSI.
We have described the ISSI strategy as though the Cre
promoted reaction occurred ﬁrst because this description is
particularly easy to follow mechanistically. In fact the order
of the two site-speciﬁc recombination reaction makes no dif-
ference to the outcome and indeed they may occur concur-
rently. The only feature of the reaction that is critical is which
of the two attachment (att) sites in the incoming vector recom-
bines with the attB or attP site adjacent to the resident select-
able marker gene.
Implementation of iterative site-specific integration
We have implemented ISSI using a combination of the Cre
recombinase and fC31 integrase. First of all we built the
necessary plasmids, BAC and PAC vectors (Figure 6). In
Figure6.PlasmidandlargeinsertvectorsusedinISSI.(A)PlasmidattPloxPHytkattPusedintheISSIsequenceshowninFigure7.(B)PlasmidattBloxPBSRattB
mod
usedin the ISSIsequenceshowninFigure7. (C) BACvectorfC31BACattPCCAGloxPHyTkattP. Thisvectordiffersfromthe othersin thatitincludesa promoter
upstreamoftheselectablemarker.Weoriginallyexpectedthatthismodificationwouldimprovetheefficiencyoftheintegrationcomparedwithapromoterlessvector
howevercomparisonsrevealedno differencein the respectiveefficiencies.Thisvector wasused in the experiments shownin Figure8. PromoterlessBACand PAC
equivalents have been engineered (Supplementary Data). (D) PAC vector fC31PAC attBloxPBSRattB
mod. This vector was used as the vector for the human X
chromosome alphoid DNA in the experiment shown in Figure 8. A BAC equivalent has been engineered (Supplementary Data).
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strated that fC31 attB sites are less recombinationally active
when integrated into vertebrate genomic DNA than when pre-
sent in cloned DNA (21). The fC31 attB site includes seven
CpG sites that are potentially methylatable in vertebrate
genomic DNA. This suggested to us that cytosine methylation
at the 50 position within these CpG dinucleotides was inhib-
iting the ability of a genomic attB site to participate in site-
speciﬁc recombination reactions. We therefore investigated
the effect of CpG methylation of the attB site upon its ability
to participate in site-speciﬁc recombination reactions in vitro.
These results (S.K.Mallaunpublisheddata)demonstratedthat
CpG methylation does indeed inhibit the ability of the attB site
to participate in fC31 mediated site-speciﬁc recombination
in vitro. We therefore devised an unmethylatable analogue
of the attB site termedattB
mod and have shown that it functions
as efﬁciently as the unmethylated native attB in vivo. We have
therefore used attB
mod in the ISSI plasmids shown in Figure 6.
Although the details of the work describing the effects of CpG
methylation of the attB site upon fC31 site-speciﬁc recomb-
ination reaction are unpublished the sequence of attB
mod is
provided in the Materials and Methods. We also used bi-
sulphite sequencing to investigate whether the attB site in
the CCAG attB HyTk construct used in the previous experi-
ments was methylated and ﬁnd that it was not (S.K. Malla
unpublished data). The initial conclusions and the numbers in
Table 1 are therefore not complicated by the consequences of
attB site methylation in vivo. The attB site in the CCAG attB
HyTk construct is located adjacent to the CpG island deﬁned
by the chicken b-actin promoter within the CCAG promoter
and thus would not be expected to be readily methylated in
vivo. However in the work described by Belteki et al. (21) the
attB site lies outside the transcribed region of the gene and not
within a CpG island and it may therefore be readily methyl-
ated. It thus remains to be established whether an inappropri-
ately placed attB site can be methylated in vivo and when it is
so methylated to what extent this inhibits site-speciﬁc recomb-
ination. Experiments to establish this point are in progress
(S. K. Malla and W. R. A. Brown).
The genes that we used in the integrating plasmids were
those conferring resistance to the antibiotics blasticidin (16)
(BSR) and hygromycin (17) (HyTk).
In order to implement ISSI we targeted the seed construct
CCAG loxP HyTk attP (Figure 5A) to the 49B(A)A9 mini-
chromosome in the same way as we had targeted the CCAG
attB HyTk construct (Figure 1B). We then introduced sequen-
tially the CCAG 50nls fC31 integrase IRES zeo (Figure 2A)
and the CCAG Cre IRES ecogpt (Supplementary Data) plas-
mids that direct expression of the fC31 integrase tagged at the
N-terminus with a nuclear localization sequence and the Cre
recombinase, respectively. This generated several cells lines
which should be capable of mediating the ISSI sequence. We
used one of these, termed ISSI 2, for our proof of principle
experiments.
In the ﬁrst of our proof of principle experiments we used
plasmids to execute two complete cycles of this strategy
(Figure 7A). This led to the integration of a concatamer of
four pBlueScript and accompanying polylinker sequences into
the target. The presence of four other plasmid vector DNA
molecules integrated into background of this cell line pre-
cluded direct analysis of the integrated DNA and so we
used restriction enzyme digestion, ﬁlter hybridization and
indirect end labelling to conﬁrm the predicted structures of
the DNA integrated during the ISSI sequence. DNA extracted
Figure 7. ISSI of plasmid vector molecules into mini-chromosome A9 CCAG loxP HyTk attP in DT40 cells. (A) Illustrates the iterations of plasmid integration
reactions into the CCAG loxP HyTK attP site present in the starting cell line ISSI 2 and analysed in (B). The positions of the substrate and product attachment (att)
sites and ofthe restrictionenzymesites used in the mappingare indicated. The cassettes usedin thesetransfections werealternately attB loxPBSR attB
modand attP
loxPHyTkattP.(B)FilterhybridizationanalysisofgenomicDNAextractedfromthecelllinesgeneratedinthesequenceindicatedinAusingprobesrecognizingthe
selectable marker genes used in the ISSI sequence. The cross hybridization to chicken DNA seen with the HyTk probe at  25 kb serves as a loading control in this
analysis.
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does not cut in pBluescript; NcoI, and then analysed
(Figure 7B) either with a probe that recognizes the gene
conferring resistance to the antibiotic Blasticidin (BSR) or
with a probe from the hygromycin resistance gene present
in the original target and in the products of the second and
fourth plasmid integration reactions. These cell lines are
referred to in Figure 7B by the number of the transfection
from which they were derived which is indicated to the left
of Figure 7A. The sizes and distribution of the cognate restric-
tion fragments in these cells lines were precisely as predicted.
At each step in the sequence of transfections illustrated in
Figure 7 we characterized  10 individual clones in order to
identify those in which the fC31 att site 50 to the incoming
marker had recombined with the resident substrate site and
which therefore had a structure that made them potentially
available for a subsequent round of integration. At each
step we found that all the recombination events were with
one or other of the two sites and that each site had recombined
with similar efﬁciency. It seemed to us possible that since ISSI
requires the coordinated action of two site-speciﬁc recom-
binases for a stable integration of the desired structure it
would be less efﬁcient than the integration reaction promoted
by the fC31 integrase alone. This was not so and ISSI
appeared to be at least as efﬁcient as the single fC31 reaction
alone for plasmid (Table 1) integrations.
In the second proof of principle experiment we started with
the product of transfection 267 described in the plasmid ISSI
experiment and successively introduced a 70 kb alphoid DNA
array derived from the human Y chromosome cloned in a
CCAG loxP HyTk attP attP BAC and a 80 kb array of alphoid
DNA derived from the human X chromosome cloned in a loxP
BSR attB attB BAC (Figure 8A and B). This led to the isola-
tion of cell line 293 containing the Y alphoid DNA and then to
cell line 419 containing both the Y and X alphoid DNA
(Figure 8B). We characterized these cell lines at successively
higher resolution by three methods. Firstly we demonstrated
that we could detect the acquisition of the alphoid DNA arrays
by PFGE of the intact mini-chromosomes (Figure 8C). Integ-
ration of the X chromosome alphoid DNA was indicated by
speciﬁc hybridization and of both sequences by a slight
increase in the size of the mini-chromosome. Secondly we
used restriction enzyme digestion, PFGE and ﬁlter hybridiza-
tion to establish physical linkage of the sequences. This ana-
lysis made use of the sequence of the junctions and the low
sequence complexity of the two sequences. Neither BglII nor
BclI cut either alphoid DNA array butBglII cuts the polylinker
junction between the two arrays. Consequently BglII releases
each different array separately but BclI releases them together
on a single large fragment of  170 kb in size and thus reveal
their linkage (Figure 8D). The BclI fragments are 20 kb longer
than the integrated DNA because the integration site itself lies
on a 20 kb BclI fragment. The 15 kb alphoid DNA cognate
fragment is increased in size in the mini-chromosomes in cell
lines 293 and 419 as compared with the mini-chromosome in
clone NLS2. This increase arises because of the introduction
of the pBluescript molecule during transfection 267 immedi-
ately prior to the generation of cell line 293 (Figure 8A).
Finally we established the presence of the predicted products
and substrates of the site-speciﬁc recombination reactions in
the starting line ISSI 2 and in the three cell lines used in the
sequence. There are nine such junctions (Figure 8B). Their
presenceorabsenceinthecelllinesisaspredicted(Figure8E);
sequence analysis (data not shown) conﬁrms the identity of the
product in each case. These results thus prove that the ISSI
functions as envisaged. The efﬁciency of the ISSI BAC trans-
formation reactions is greater (Table 2) than seen with the
fC31 integrase alone which is consistent with the results
seen with plasmids.
DISCUSSION
The experiments described here demonstrate that the fC31
integrase speciﬁcally and efﬁciently promotes site-speciﬁc
integration in chicken DT40 cells. The observation that
these proteins function in vertebrate cells is consistent with
earlier work showing that the puriﬁed fC31 integrase pro-
motes unidirectional exchange reactions between attB and
attP sites in vitro (11) and with some aspects of the results
of others who have studied either the fC31 and R4 (21,22)
integrases in mammalian cells.
We have shown that integration of intact 140 kb BACs into
vertebrate cells is very inefﬁcient because they usually break
before they integrate. The breakage does not appear to reﬂect
the integrity prior to electroporation because the DNA was
puriﬁed as closed circular by equilibrium centrifugation on a
caesium chloride gradient in the presence of ethidium bromide
and was assessed as intact by PFGE. Although there have been
some reports of the successful electroporation of BACs into
mammalian cells (23) others have reported problems (24) and
have developed episomal vector systems in order to partially
overcome them. We therefore conclude that the problem of
integrating intact, large BACs into genomic DNA might be a
general one.
We have addressed the problem of integrating large seg-
ments of DNA by establishing a strategy that combines the
activities of the fC31 integrase and Cre recombinase to permit
iterative integration of transgenic sequences. The strategy that
we have implemented is termed ISSI is just one of several that
one may envisage in which the activities of one or more uni-
directional enzymes are combined with either the activity of a
reversible recombinase or homologous recombination to per-
mit serial or iterative integration. In one of these the activity of
Cre is combined with that of two homing nucleases or mega-
nucleases, oligonucleotides and T4 ligase and has been used
for multiple rounds of integration into cloned DNA in vitro
(25). The use of the two meganucleases rather than a single
unidirectional enzyme allowed a single unambiguous resolu-
tion product to be generated at each half of the cycle but this is
not necessary when one wishes to assemble an array in vivo
because one would wish to check the integrants for their integ-
rity at each stage. Qualitatively ISSI works exactly as anticip-
ated but quantitatively ISSI works better than one might have
supposed. The reaction sequence that leads to the integration
of one marker and excision of another is not known but the
efﬁciency with which these steps occur relative to that of a
single fC31 integrase integration reaction suggests that the
fC31 integrase and the Cre are cooperating at the rate-limiting
step. Such cooperativity could arise if the rate-limiting step
was the association of the incoming DNA with the genomic
target and both the Cre recombinase and the fC31 integrase
bound to each of their respective target sites. This would allow
PAGE 11 OF 14 Nucleic Acids Research, 2005, Vol. 33, No. 22 e189Figure 8. ISSI of large fragments molecules into mini-chromosome A9 CCAG loxP HyTk attP in DT40 cells. (A) Illustrates the iterations of plasmid and large
fragmentintegrationreactionsintothe CCAGloxPHyTKattP sitepresent in thestartingcell lineISSI 2and analysedin (C–E).The cell lineISSI 2was transfected
with the plasmid attBloxPBSRattB to yield cell line 267 as described in Figure 7. This cell line was then transfected sequentially with a BAC containing 70 kb of Y
alphoid DNA cloned in fC31BAC/PCCAGloxPHyTkP to yield cell line 293 and then with a PAC containing 80 kb of X alphoid DNA cloned in fC31PAC/
BloxPBSRB to yield cell line 419. The recombination sites analysed by PCR in section E below are indicated. (B) Pulsed-field gel analysis of 80 kb X and 70 kbY
alphoidDNAclonedintheBACandPACvectorsusedtotransfectthecellsasdescribedinA.TheDNAwasdigestedwithNotI,whichexcisestheinsert,priortogel
electrophoresis. The image is of an ethidium bromide stained gel. (C) PFGE and filter hybridization analysis of the intact modified mini-chromosomes in cell lines
293and419.Thecontrolisthemini-chromosomeisolatedfromthecelllineA9-CCAGattBHykfC31-50NLS2(abbreviatedNLS2)modifiedwithCCAGattBHyTk
andexpressingthefC31integrase.ThisfiltertransferswereprobedwithYandXalphoidDNAsequencesandillustratetheincrementalincreaseinsizeofthemini-
chromosome that follows from the introduction of the 70 and 80 kb alphoid Y and X alphoid DNA sequences. (D) Restriction enzyme mapping of the integrated
alphoid DNA sequences. DNA extracted from the indicated cell lines was digested with either BglII or BclI, size fractionated by PFGE, filter transferred and the
transferprobedwitheitherXorYalphoidDNAsequences.BglIIbutnotBclIcutstheintegratedDNAsequencesatthejunctionsbetweentheinsertandvector.The
BglII digests therefore identify the DNA sequences that have been introduced into the chromosome while the co-hybridization of the 170 kb fragment in the BclI
digest of the 419 cell line establishes linkage between the Y and X alphoid DNA sequences as predictedin (A). (E) Identification by PCR of the predicted junctions
indicated in (A).
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the afﬁnity of participating DNA molecules for one another
and their overall rates of reaction.
The observation that the two attachment sites in the incom-
ing circular DNA recombine equally efﬁciently with the recip-
rocal genomic attachment site is at ﬁrst surprising. A linear
representation of a coordinate reaction process might lead one
to suppose that the 30 site in the incoming DNA would be
stereo-chemically favoured. Our observation may reﬂect a
two-step process as envisaged in Figure 5 or the fact that
both participating DNA molecules are folded in three dimen-
sions and that recombination between the loxP sites favour
neither the 30 nor the 50 attachment sites.
Vertebrate centromeres are typically composed of several
hundred kilobasepairs of tandemly repeated sequences. We
have demonstrated that ISSI will enable us to build such struc-
tures. We anticipate that ISSI may also be applied to other
problems of experimental transgenesis where it is necessary to
combine and assemble multiple transgenes. In some of these it
will be simpler to ‘stack’ (25) the transgenes in vitro prior to
their introduction into the genome but in others, where one
wishes,forexample,tointroducelongerstretches ofDNA,this
will be impractical and in vivo assembly will be the only
option. Examples include the assembly of large genomic
regions for the purpose of investigating distally locatedcontrol
elements, reconstruction of complex loci such as the major
histocompatibility complex as transgenes and the synthesis of
bacterial genomes (7). Although we have carried out two
proofs of principle experiments it remains to be proven
how well ISSI works in cells other than those of the chicken
DT40 line. We have argued in the introduction that our experi-
mental approach is robust in so far as we have shown that we
can integrate unstable sequences into a hyper-recombinogenic
cell line. One limitation may be how well the unidirectional
integrase works in different cell types. fC31 integrase itself
has been shown to function in mouse, human, ﬁssion yeast and
Drosophila cells [reviewed in (26)]. Some uncertainty also
surrounds the ease with which large DNA fragments may
be introduced into both eukaryotic and prokaryotic cells. Nev-
ertheless BACs are routinely introduced into E.coli cells (27)
and have been transferred into mouse and human ﬁbroblasts
(24). Similarly large DNA fragments may be readily intro-
duced into both budding (28) and ﬁssion yeast (29). This body
of work suggests that size of the transfected DNA will not
fundamentally limit the implementation of ISSI in a wide
variety of cell types. Consistently in unpublished data we
have used three rounds of ISSI to construct a 210 kb transgene
in Chinese hamster ovary cells. In these experiments the fBT1
integrase (30) rather than the fC31 integrase was used as the
unidirectional component in the reaction. Despite these argu-
ments and encouraging preliminary results only sustained
application in a variety of systems will establish the utility
and limitations of our technique.
SUPPLEMENTARY DATA
Supplementary Data is available at NAR Online.
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